237 employees
Avanir Pharmaceuticals is a biopharmaceutical company focused on providing medicines to patients with central nervous system disorders.
1988
$30M
from 3 investors over 3 rounds
Avanir Pharmaceuticals raised $30M on June 26, 2012
Investors: Oxford Finance LLC
Avanir Pharmaceuticals raised $16M on October 18, 2005
Investors: Jennison Associates LLC and OrbiMed Advisors